B.E. de Pauw
- Infectious Diseases top 0.5%
- Epidemiology top 1%
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Clinical Biochemistry top 1%
- Co-authors
- J. Peter DonnellyJacques F. MeisPaul E. VerweijJ. A. A. Hoogkamp‐KorstanjeWillem J. G. MelchersAntonius J. M. M. RijsAlex van BelkumNicole M. A. Blijlevens
- Topics
- Antifungal resistance and susceptibility (44 papers)Neutropenia and Cancer Infections (37 papers)Fungal Infections and Studies (37 papers)
- Journals
- New England Journal of MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- NetherlandsBelgiumUnited States
In The Last Decade
B.E. de Pauw
117 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 121
- Infectious Diseases 1.8k
- Epidemiology 1.7k
- Oncology 988
- Pulmonary and Respiratory Medicine 503
- Clinical Biochemistry 370
Countries citing papers authored by B.E. de Pauw
This map shows the geographic impact of B.E. de Pauw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.E. de Pauw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.E. de Pauw more than expected).
Fields of papers citing papers by B.E. de Pauw
This network shows the impact of papers produced by B.E. de Pauw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.E. de Pauw. The network helps show where B.E. de Pauw may publish in the future.
Co-authorship network of co-authors of B.E. de Pauw
This figure shows the co-authorship network connecting the top 25 collaborators of B.E. de Pauw. A scholar is included among the top collaborators of B.E. de Pauw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.E. de Pauw. B.E. de Pauw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 40 | |
| 2 | 394 | |
| 3 | 18 | |
| 4 | 28 | |
| 5 | Caspofungin versus liposomal amphotericin B for empirical therapy. | 1 |
| 6 | Microbiologic consequences of new approaches to managing hematologic malignancies. | 6 |
| 7 | 28 | |
| 8 | 46 | |
| 9 | 13 | |
| 10 | 7 | |
| 11 | 1 | |
| 12 | Controversies in management of candidiasis in neutropenic patients treated for malignant diseases: new versus old or better versus worse | 2 |
| 13 | 3 | |
| 14 | 26 | |
| 15 | 40 | |
| 16 | 30 | |
| 17 | 73 | |
| 18 | 36 | |
| 19 | 7 | |
| 20 | 5 |
About B.E. de Pauw
B.E. de Pauw is a scholar working on Infectious Diseases, Clinical Biochemistry and Oncology, having authored 119 papers that have together received 3.4k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (44 papers), Neutropenia and Cancer Infections (37 papers) and Fungal Infections and Studies (37 papers). The work is most often cited by research in Infectious Diseases (1.8k citations), Clinical Biochemistry (370 citations) and Epidemiology (1.7k citations). B.E. de Pauw has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include J. Peter Donnelly, Jacques F. Meis, Paul E. Verweij, J. A. A. Hoogkamp‐Korstanje, Willem J. G. Melchers, Antonius J. M. M. Rijs, Alex van Belkum, Nicole M. A. Blijlevens, John Raemaekers and I.R.O. Nováková. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.